Pulmonology focuses on diagnosing and treating lung and airway conditions such as asthma, COPD, and pneumonia, as well as overall respiratory health.
Send us all your questions or requests, and our expert team will assist you.
Influenza is a highly contagious acute respiratory illness caused by influenza viruses that infect the nose, throat, and lungs. While often confused with the common cold due to overlapping symptoms, influenza represents a distinct and significantly more severe pathology capable of causing widespread morbidity and mortality. The disease is characterized by a sudden onset of constitutional and respiratory symptoms resulting from the viral invasion of the respiratory epithelium. This viral proliferation triggers a robust immune response, releasing a cascade of inflammatory cytokines that drive the patient’s intense systemic manifestations. At Liv Hospital, we approach influenza not merely as a seasonal nuisance but as a severe systemic infection requiring vigilant monitoring, precise biological understanding, and comprehensive management strategies to prevent severe complications in vulnerable populations.
The causative agents of this disease belong to the Orthomyxoviridae family of RNA viruses. These pathogens are enveloped viruses with a segmented genome, a feature that plays a critical role in their ability to mutate and evade the human immune system.
Classification of Viral Types
There are four types of influenza viruses: A, B, C, and D. Influenza A and B viruses cause seasonal epidemics of disease in people. Influenza A viruses are the only influenza viruses known to cause flu pandemics. They are divided into subtypes based on two viral surface proteins: hemagglutinin (H) and neuraminidase (N). Influenza B viruses are not divided into subtypes but are grouped into lineages. Influenza C causes mild illness, and Influenza D primarily affects cattle.
The Mechanism of Viral Replication
The replication cycle begins when the viral hemagglutinin binds to sialic acid receptors on the surface of human respiratory tract cells. Following receptor-mediated endocytosis, the virus enters the cell cytoplasm. The acidic environment within the endosome triggers the fusion of the viral envelope with the endosomal membrane, releasing the viral RNA into the cytoplasm. This genetic material then migrates to the nucleus, hijacking the host cell’s machinery to produce new viral components. Neuraminidase then facilitates progeny virus release, allowing them to infect adjacent cells and continue the cycle of infection.
The elusive nature of the influenza virus and the necessity for annual vaccination are driven by two primary evolutionary mechanisms known as antigenic drift and antigenic shift.
Antigenic Drift
This process involves small genetic mutations that accumulate over time as the virus replicates. These mutations affect the surface proteins, hemagglutinin and neuraminidase. Because these proteins are the primary targets for the immune system’s antibodies, changes in their structure can allow the virus to escape recognition by the immune system, even in individuals who have been previously infected or vaccinated. This constant, gradual change is the primary reason why the composition of the seasonal flu vaccine must be updated annually to match the circulating strains.
Antigenic Shift
This is a more abrupt and significant change in influenza A viruses, resulting in a new hemagglutinin and, sometimes, a new neuraminidase protein in viruses that infect humans. Shift results in a new influenza A subtype. This phenomenon typically occurs when an influenza virus from an animal population gains the ability to infect humans or when two different strains infect the same host cell and exchange genetic material. Because the human population has little to no immunity against the new subtype, antigenic shift can lead to widespread pandemics with high infection rates.
Influenza is a global health challenge with a distinct seasonal pattern in temperate climates, typically peaking during the winter months. In the Northern Hemisphere, activity can begin as early as October and last until May. In tropical regions, influenza can occur year-round. The World Health Organization estimates that annual epidemics result in about three to five million cases of severe illness and hundreds of thousands of deaths globally. The transmission dynamics are influenced by environmental factors such as humidity and temperature, as well as human behavior, including indoor crowding during colder months. Understanding these patterns is essential for healthcare systems to prepare for the surge in patient volume and critical care needs.
Upon infection, the virus targets the columnar epithelial cells of the respiratory tract. Viral replication leads to cellular necrosis and desquamation of the respiratory lining. This destruction of the physical barrier exposes the underlying basement membrane, leading to edema, hyperemia, and increased mucous secretion. The host’s immune response involves the infiltration of neutrophils and mononuclear cells. This local inflammation can extend from the upper respiratory tract down to the alveoli in the lungs. In severe cases, this can result in primary viral pneumonia, characterized by interstitial inflammation and hemorrhage, severely compromising gas exchange and leading to acute respiratory distress syndrome.
Many influenza A viruses commonly infect animals such as birds and pigs. Avian influenza refers to the disease caused by infection with avian (bird) influenza Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. On rare occasions, avian influenza viruses can infect people and cause disease ranging from mild upper respiratory infection to severe pneumonia. The concern with zoonotic viruses is their potential to adapt to efficient human-to-human transmission, posing a threat of a new pandemic. Surveillance of these animal reservoirs is a critical component of global public health strategy.
The history of influenza is marked by significant pandemics that have shaped public health policy. The most notable was the 1918 pandemic, often cited as the most severe in recent history. Other important events include the 1957, 1968, and 2009 pandemics. These events underscore the virus’s unpredictable nature and the catastrophic potential of antigenic shift. Studying these historical outbreaks provides valuable data regarding transmission rates, mortality curves, and the effectiveness of non-pharmaceutical interventions. This historical perspective informs current preparedness plans at institutions like Liv Hospital, ensuring readiness for future epidemiological challenges.
Beyond the clinical impact, influenza imposes a substantial economic burden on society. This includes direct medical costs for hospitalizations, outpatient visits, and medications. Indirect costs are even higher, resulting from lost workforce productivity due to illness and the need to care for sick family members. School absenteeism during outbreaks can disrupt educational continuity. The burden is particularly heavy during years when the vaccine strain does not perfectly match the circulating virus. Public health initiatives aimed at increasing vaccination rates are driven not only by health outcomes but also by the need to mitigate broader socioeconomic impacts.
At Liv Hospital, we recognize that influenza is more than just a seasonal ailment; it is a complex viral interaction that requires a sophisticated medical response. Our approach integrates advanced diagnostic capabilities with compassionate clinical care. We emphasize the importance of distinguishing influenza from other respiratory pathogens to implement appropriate isolation protocols and targeted therapies. Our multidisciplinary teams, including infectious disease specialists, pulmonologists, and critical care physicians, collaborate to manage the spectrum of disease from mild outpatient cases to severe respiratory failure. We are committed to patient education regarding prevention and the early recognition of complications.
Send us all your questions or requests, and our expert team will assist you.
The influenza virus causes influenza, types A, B, and occasionally C, which infects the respiratory system and triggers a systemic immune response.
No, the term “stomach flu” is a misnomer; influenza is a respiratory disease, while gastrointestinal illnesses are typically caused by viruses like norovirus or rotavirus.
Antigenic drift involves small genetic changes over time and requires annual vaccine updates, while antigenic shift involves a significant change that creates a new virus subtype capable of causing pandemics.
Influenza viruses survive better in cold, dry air, and people tend to spend more time indoors during winter, which facilitates transmission.
Yes, certain strains, such as avian influenza and swine flu, can cross the species barrier from birds or pigs to humans, though sustained human-to-human transmission is rare.
Your Comparison List (you must select at least 2 packages)
